Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1983 1
1984 1
1985 1
1986 1
1987 2
1988 1
1989 2
1990 2
1991 3
1992 4
1993 4
1994 2
1995 3
1996 4
1997 2
1998 3
1999 7
2000 8
2001 4
2002 10
2003 6
2004 8
2005 6
2006 7
2007 8
2008 8
2009 16
2010 10
2011 13
2012 19
2013 24
2014 30
2015 24
2016 32
2017 21
2018 30
2019 27
2020 45
2021 32
Text availability
Article attribute
Article type
Publication date

Search Results

392 results
Results by year
Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results. The following terms were ignored: %, %, %, % The following terms were not found in PubMed: 22Serra, 5BAuthor
Page 1
Biologics for chronic rhinosinusitis.
Chong LY, Piromchai P, Sharp S, Snidvongs K, Philpott C, Hopkins C, Burton MJ. Chong LY, et al. Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD013513. doi: 10.1002/14651858.CD013513.pub2. Cochrane Database Syst Rev. 2020. PMID: 32102112 Free PMC article. Updated.
At 24 weeks, the SNOT-22 score was 19.61 points lower (better) in participants receiving dupilumab (mean difference (MD) -19.61, 95% confidence interval (CI) -22.54 to -16.69; 3 studies; 784 participants; high certainty). ...Anti-IL-5 mAb (mepolizumab) versusplacebo …
At 24 weeks, the SNOT-22 score was 19.61 points lower (better) in participants receiving dupilumab (mean difference (MD) -19.61, 95% …
Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
Lamb SE, Mistry D, Alleyne S, Atherton N, Brown D, Copsey B, Dosanjh S, Finnegan S, Fordham B, Griffiths F, Hennings S, Khan I, Khan K, Lall R, Lyle S, Nichols V, Petrou S, Zeh P, Sheehan B. Lamb SE, et al. Health Technol Assess. 2018 May;22(28):1-202. doi: 10.3310/hta22280. Health Technol Assess. 2018. PMID: 29848412 Free PMC article. Clinical Trial.
Carer outcomes were HRQoL (Quality of Life in Alzheimer's Disease) (as measured using the EQ-5D-3L) and carer burden (as measured using the Zarit Burden Interview). ...FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology A …
Carer outcomes were HRQoL (Quality of Life in Alzheimer's Disease) (as measured using the EQ-5D-3L) and carer burden (as measured usi …
Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: A case-control study.
Verlaan S, Aspray TJ, Bauer JM, Cederholm T, Hemsworth J, Hill TR, McPhee JS, Piasecki M, Seal C, Sieber CC, Ter Borg S, Wijers SL, Brandt K. Verlaan S, et al. Clin Nutr. 2017 Feb;36(1):267-274. doi: 10.1016/j.clnu.2015.11.013. Epub 2015 Nov 27. Clin Nutr. 2017. PMID: 26689868 Free article.
Health-related quality of life, self-reported physical activity levels and dietary intakes were measured using the EQ-5D scale and index, Physical Activity Scale for the Elderly (PASE), and 3-day prospective diet records, respectively. ...RESULTS: In addition to the define …
Health-related quality of life, self-reported physical activity levels and dietary intakes were measured using the EQ-5D scale and in …
Platelet-rich plasma versus Tenex in the treatment of medial and lateral epicondylitis.
Boden AL, Scott MT, Dalwadi PP, Mautner K, Mason RA, Gottschalk MB. Boden AL, et al. J Shoulder Elbow Surg. 2019 Jan;28(1):112-119. doi: 10.1016/j.jse.2018.08.032. J Shoulder Elbow Surg. 2019. PMID: 30551782
METHODS: In this retrospective review, 62 of 75 patients were available for contact via phone and e-mail to complete post-procedure patient-reported outcome surveys. ...RESULTS: The average ages in the PRP and Tenex groups were 47 years and 51 years, respectively. The PRP …
METHODS: In this retrospective review, 62 of 75 patients were available for contact via phone and e-mail to complete post-procedure p …
Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins.
Brittenden J, Cooper D, Dimitrova M, Scotland G, Cotton SC, Elders A, MacLennan G, Ramsay CR, Norrie J, Burr JM, Campbell B, Bachoo P, Chetter I, Gough M, Earnshaw J, Lees T, Scott J, Baker SA, Tassie E, Francis J, Campbell MK. Brittenden J, et al. N Engl J Med. 2019 Sep 5;381(10):912-922. doi: 10.1056/NEJMoa1805186. N Engl J Med. 2019. PMID: 31483962 Free article. Clinical Trial.
Primary outcomes at 5 years were disease-specific quality of life and generic quality of life, as well as cost-effectiveness based on models of expected costs and quality-adjusted life-years (QALYs) gained that used data on participants' treatment costs and scores on the EuroQol …
Primary outcomes at 5 years were disease-specific quality of life and generic quality of life, as well as cost-effectiveness based on models …
Screw Fixation Versus Hemiarthroplasty for Nondisplaced Femoral Neck Fractures in Elderly Patients: A Multicenter Randomized Controlled Trial.
Dolatowski FC, Frihagen F, Bartels S, Opland V, Šaltytė Benth J, Talsnes O, Hoelsbrekken SE, Utvåg SE. Dolatowski FC, et al. J Bone Joint Surg Am. 2019 Jan 16;101(2):136-144. doi: 10.2106/JBJS.18.00316. J Bone Joint Surg Am. 2019. PMID: 30653043 Clinical Trial.
Assessors blinded to the type of treatment evaluated hip function with the Harris hip score (HHS) as the primary outcome as well as on the basis of mobility assessed with the timed "Up & Go" (TUG) test, pain as assessed on a numerical rating scale, and quality of life as asse …
Assessors blinded to the type of treatment evaluated hip function with the Harris hip score (HHS) as the primary outcome as well as on the b …
Abdominal massage plus advice, compared with advice only, for neurogenic bowel dysfunction in MS: a RCT.
McClurg D, Harris F, Goodman K, Doran S, Hagen S, Treweek S, Norton C, Coggrave M, Norrie J, Rauchhaus P, Donnan P, Emmanuel A, Manoukian S, Mason H. McClurg D, et al. Health Technol Assess. 2018 Oct;22(58):1-134. doi: 10.3310/hta22580. Health Technol Assess. 2018. PMID: 30375324 Free PMC article. Clinical Trial.
BACKGROUND: Between 50% and 80% of people with multiple sclerosis (PwMS) experience neurogenic bowel dysfunction (NBD) (i.e. constipation and faecal incontinence) that affects quality of life and can lead to hospitalisation. ...FUNDING: This project was funded by the Natio …
BACKGROUND: Between 50% and 80% of people with multiple sclerosis (PwMS) experience neurogenic bowel dysfunction (NBD) (i.e. constipa …
6a-Nitro-6-(2,2,7,7-tetra-methyl-tetra-hydro-3aH-bis-[1,3]dioxolo[4,5-b:4',5'-d]pyran-5-yl)-6a,6b,7,8,9,11a-hexa-hydro-6H-spiro-[chromeno[3,4-a]pyrrolizine-11,11'-indeno-[1,2-b]quinoxaline].
Anuradha T, Naga Siva Rao J, Seshadri PR, Raghunathan R. Anuradha T, et al. Acta Crystallogr Sect E Struct Rep Online. 2013 Dec 14;70(Pt 1):o38-9. doi: 10.1107/S1600536813032467. eCollection 2014 Jan 1. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 24526984 Free PMC article.
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial.
Frumovitz M, Obermair A, Coleman RL, Pareja R, Lopez A, Ribero R, Isla D, Rendon G, Bernardini MQ, Buda A, Moretti-Marquez R, Zevallos A, Vieira MA, Zhu T, Land RP, Nicklin J, Asher R, Robledo KP, Gebski V, Ramirez PT. Frumovitz M, et al. Lancet Oncol. 2020 Jun;21(6):851-860. doi: 10.1016/S1470-2045(20)30081-4. Lancet Oncol. 2020. PMID: 32502445 Clinical Trial.
Eligible patients completed validated quality-of-life and symptom assessments (12-item Short Form Health Survey [SF-12], Functional Assessment of Cancer Therapy-Cervical [FACT-Cx], EuroQoL-5D [EQ-5D], and MD Anderson Symptom Inventory [MDASI]) before surgery and at …
Eligible patients completed validated quality-of-life and symptom assessments (12-item Short Form Health Survey [SF-12], Functional Assessme …
Intramedullary nail fixation versus locking plate fixation for adults with a fracture of the distal tibia: the UK FixDT RCT.
Costa ML, Achten J, Hennings S, Boota N, Griffin J, Petrou S, Maredza M, Dritsaki M, Wood T, Masters J, Pallister I, Lamb SE, Parsons NR. Costa ML, et al. Health Technol Assess. 2018 May;22(25):1-148. doi: 10.3310/hta22250. Health Technol Assess. 2018. PMID: 29785926 Free PMC article. Clinical Trial.
The secondary outcomes were the Olerud-Molander Ankle Score (OMAS), quality of life as measured using EuroQol-5 Dimensions (EQ-5D), complications such as infection, and further surgery. Resource use was collected to inform the health economic evaluation. ...FUNDING: This p …
The secondary outcomes were the Olerud-Molander Ankle Score (OMAS), quality of life as measured using EuroQol-5 Dimensions (EQ-5D), c …
392 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page